Abdul Rahman bin Mohammed Al Owais issues decree to reduce prices of 410 drugs from September 15
Abdul Rahman bin Mohammed Al Owais, the UAE's Minister of Health, has issued a decree to reduce the price of 410 drugs.
The move is in line with the government's directives to provide medicines at competitive prices and compatible with the lowest price in the Gulf region, a statement said.
The price reduction will take effect from September 15, with the list of medicines including a wide range for the treatment of cardiovascular diseases, hypertension, lipid-lowering drugs and angina drugs, which are common chronic diseases in the region.
The prices will be cut by between 2-77 percent, of which 183 varieties are locally manufactured and 227 manufactured regionally and globally.
The Ministry of Health and Prevention (MoHAP) addressed pharmaceutical companies at a recent meeting to coordinate joint efforts to support patients.
It said its initiative to reduce prices would also deter patients from seeking cheaper options online which can be counterfeit.
MoHAP commended the "positive and rapid response" of pharmaceutical companies to reduce the prices.